Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00757185 · ClinicalTrials.gov registry record · Early Phase 1
Compromised Microcirculation in Women With Polycystic Ovary Syndrome
A Early Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 28
- Enrollment target
NCT00757185 is a Early Phase 1 study that has completed, run by Yale University. The registered enrollment target is 28 participants.
The verdict
NCT00757185, a Early Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The scientific aims of the study are to determine how peripheral microcirculatory responsiveness is altered in obese women with Polycystic Ovary Syndrome (PCOS) during local heating and to determine the mechanism for testosterone effects on peripheral microcirculatory responsiveness in women with PCOS.
Interventions
- DRUG ganirelix acetate
- DRUG methyl testosterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2008-02 |
| Est. Completion | 2012-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00757185
The ClinicalTrials.gov registry entry for NCT00757185 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ganirelix acetate is the first listed.
NCT00757185 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00757185 about?
NCT00757185 is a clinical study titled "Compromised Microcirculation in Women With Polycystic Ovary Syndrome". The scientific aims of the study are to determine how peripheral microcirculatory responsiveness is altered in obese women with Polycystic Ovary Syndrome (PCOS) during local heating and to determine the mechanism for testosterone effects on peripheral microcirculatory responsiveness in women with PC...
What is the current status of trial NCT00757185?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 28 participants. The study started on 2008-02. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00757185?
The interventions under investigation include: ganirelix acetate (DRUG), methyl testosterone (DRUG).
Who is sponsoring clinical trial NCT00757185?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.